These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 10516550)

  • 41. Requirements for blood and blood components intended for transfusion or for further manufacturing use. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2015 May; 80(99):29841-906. PubMed ID: 26003966
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Blood surveillance in Europe].
    Faber JC
    Transfus Clin Biol; 2000 Feb; 7(1):5-8. PubMed ID: 10730340
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Use of blood-donor and transfusion-recipient biospecimen repositories to address emerging blood-safety concerns and advance infectious disease research: the National Heart, Lung, and Blood Institute Biologic Specimen Repository.
    Busch MP; Glynn SA
    J Infect Dis; 2009 Jun; 199(11):1564-6. PubMed ID: 19385737
    [No Abstract]   [Full Text] [Related]  

  • 44. ISBT Board response to the Dublin consensus statement.
    Flanagan P
    Vox Sang; 2011 Feb; 100(2):250-1. PubMed ID: 20946536
    [No Abstract]   [Full Text] [Related]  

  • 45. [What is the use of hemovigilance?].
    Quaranta JF; Canivet N
    Transfus Clin Biol; 1998 Dec; 5(6):415-21. PubMed ID: 9894333
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Emily Cooley Memorial Award. Managing change to improve transfusion safety.
    AuBuchon JP
    Transfusion; 2004 Sep; 44(9):1377-83. PubMed ID: 15318865
    [No Abstract]   [Full Text] [Related]  

  • 47. Transfusion medicine: looking to the future.
    Goodnough LT; Shander A; Brecher ME
    Lancet; 2003 Jan; 361(9352):161-9. PubMed ID: 12531595
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Blood transfusion and supply chain management safety].
    Quaranta JF; Caldani C; Cabaud JJ; Chavarin P; Rochette-Eribon S
    Presse Med; 2015 Feb; 44(2):214-20. PubMed ID: 25578550
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Progress toward strengthening national blood transfusion services--14 countries, 2008-2010.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2011 Nov; 60(46):1577-82. PubMed ID: 22108537
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prevalence of HIV-1 in blood donations following implementation of a structured blood safety policy in South Africa.
    Heyns Adu P; Benjamin RJ; Swanevelder JP; Laycock ME; Pappalardo BL; Crookes RL; Wright DJ; Busch MP
    JAMA; 2006 Feb; 295(5):519-26. PubMed ID: 16449617
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Safety of the blood supply.
    Fiebig E
    Clin Orthop Relat Res; 1998 Dec; (357):6-18. PubMed ID: 9917695
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Safer haemotherapy: the responsibilities of government, transfusion service, blood donors, and physician-users.
    Moore BP
    Haematologia (Budap); 1995; 27(1):39-45. PubMed ID: 12051295
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Transfusion safety: is this the business of blood centers?
    Slapak C; Fredrich N; Wagner J
    Transfusion; 2011 Dec; 51(12 Pt 2):2767-71. PubMed ID: 22150688
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Risk management in transfusion medicine. The AIDS era underscores the need for a unified, comprehensive risk management program for all aspects of transfusion--from donor selection to post-transfusion outcomes.
    Berte LM; Dechristopher PJ
    MLO Med Lab Obs; 1996 Mar; 28(3):28-34. PubMed ID: 10156309
    [No Abstract]   [Full Text] [Related]  

  • 55. AIDS and the blood supply: an analysis of law, regulation, and public policy.
    Salbu SR
    Wash Univ Law Q; 1996; 74(4):913-80. PubMed ID: 16273697
    [No Abstract]   [Full Text] [Related]  

  • 56. Trends in major transfusion-transmissible infections among blood donors over 17 years in Istanbul, Turkey.
    Kocak N; Hepgul S; Ozbayburtlu S; Altunay H; Ozsoy MF; Kosan E; Aksu Y; Yilmaz G; Pahsa A
    J Int Med Res; 2004; 32(6):671-5. PubMed ID: 15587762
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Transposition of the Blood Directive into national law--the perspective of Portugal.
    Gonçalves MH; Muon MC; Gonçalves Jd
    Transfus Clin Biol; 2005 Feb; 12(1):18-20. PubMed ID: 15814287
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Minimal exposure transfusion concept.
    Menitove JE
    J Clin Apher; 1991; 6(4):194-5. PubMed ID: 1816237
    [No Abstract]   [Full Text] [Related]  

  • 59. [Epidemiological support in blood surveillance].
    Salmi LR
    Transfus Clin Biol; 1994; 1(6):421-4. PubMed ID: 7881586
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Seventeen years of haemovigilance in France: assessment and outlook].
    Carlier M; Vo Mai MP; Fauveau L; Ounnoughene N; Sandid I; Renaudier P
    Transfus Clin Biol; 2011 Apr; 18(2):140-50. PubMed ID: 21474356
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.